Arctic Vision: China NMPA clears Arctic Vision's IND application for phase III study of ARVN003 to treat presbyopia
Arctic Vision, a China─based ophthalmic biotech focusing on breakthrough therapies, with a leading portfolio covering pre─clinical stage to commercial stage products, announced the clearance of the
Read full article »
Arctic Vision is a biotechnology company that develops and commercializes novel therapeutics for the treatment of eye disorders.
Read more